The "Adult Malignant Glioma Therapeutics Market Research and Outlook, 2020 – Trends, Growth Opportunities and Forecasts to 2028" report has been added to ResearchAndMarkets.com’s offering. Adult ...
A gentle therapy: Weekly epirubicin, as second-line treatment in elderly patients with malignant pleural mesothelioma (MPM). Phase I study of TRC102 in combination with cisplatin and pemetrexed in ...
A phase III randomized trial of pleurectomy/decortication plus chemotherapy with or without adjuvant hemithoracic intensity-modulated pleural radiation therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results